GLP-1 Weight Loss
Tirzepatide
The dual-agonist GLP-1 / GIP program — the strongest trial results in the class, titrated with the discipline it deserves.
Available by consultation
Clinical Overview
How Tirzepatide works
The first medication in its class to engage two metabolic pathways at once — and the reason its trial outcomes set a new ceiling.
Engages the GIP receptor
Targets glucose-dependent insulinotropic polypeptide — a metabolic pathway most weight-management medications never touch.
Engages the GLP-1 receptor
Simultaneously mimics GLP-1 — suppressing appetite and slowing how quickly food leaves the stomach.
Combined metabolic effect
The dual mechanism produces the highest average weight loss recorded in any GLP-1-class clinical trial to date.
Candidacy Profiling
A considered fit, not a funnel.
Adults who want the most advanced GLP-1-class protocol available — with the supervision and careful titration this medication requires.
- Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions
- Patients who plateaued on a single-agonist GLP-1 and want to escalate under supervision
- People for whom faster onset and higher trial averages are clinically appropriate
- Personal or family history of medullary thyroid carcinoma or MEN 2
- Pregnancy, breastfeeding, or planning pregnancy
- Active pancreatitis or untreated severe gastrointestinal disease
Expected Timeline
What to Expect
Tirzepatide tends to act faster and reach further than single-agonist GLP-1s. Your provider titrates carefully to the dose that fits your body.
- 01
Month 1
Titration
Faster initial response than single-agonist GLP-1s. Careful dose escalation begins.
- 02
Month 3
Established
Therapeutic dose reached. Strong metabolic momentum; appetite consistently reduced.
- 03
Month 6
~20%
Average body weight reduction in published trials. Many patients exceed this range.
- 04
Year 1+
Sustained
Sustained reduction for the majority of patients who remain in the program.
Outcomes referenced from SURMOUNT-1 trial data. Individual results depend on starting weight, dose, and adherence.
Your Concierge Support
A licensed clinician, matched to you.
Eviora MD is powered by licensed, provider-supervised clinicians specializing in GLP-1 weight loss and peptide therapy. Every patient gets a plan reviewed by a licensed provider, secure messaging on your schedule, and a team that stays on your case through the whole arc of your progress.
- 01Compounded medication
- Prepared by partner compounding pharmacies and shipped on a structured cadence.
- 02Dedicated provider
- Every interaction is coordinated by our licensed care team — never a rotating call center.
- 03Provider-directed dosing
- Titration and adjustments at every transition, calibrated to your response.
- 04Direct message access
- Reach your care team directly between scheduled check-ins via your secure patient portal.
- 05Structured check-ins
- Cadenced reviews that keep your protocol matched to how your body is actually responding.
- 06Discreet direct delivery
- Temperature-controlled, unmarked packaging delivered straight to your door.
The Eviora Way
Care that's calibrated, not copied.
- 01.Provider-Led, Always
- A licensed provider reviews your health profile before anything is prescribed — and stays on your case as your plan evolves.
- 02.Calibrated to You
- Dosing is titrated to your biology and your pace. Your plan is reviewed and refined as your body responds.
- 03.With You for the Whole Arc
- Check-ins, secure messaging, and discreet delivery — from your first assessment to the day you hit maintenance.
Clinical Safety
No medication is right for everyone.
Common side effects
Most common during titration: nausea, decreased appetite, and digestive changes. Typically mild and resolve as the body adjusts to each step in the protocol.
Clinical Contraindications
Not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2, or for patients who are pregnant or breastfeeding. Full medical history is reviewed before any prescription is authorized.
Eviora MD protocols are prepared by partner compounding pharmacies in the United States. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed. The active ingredient is prepared per your protocol — supervised by your provider — and delivered direct to your door.
Clinical Experience
From members of the Tirzepatide program.
- “
Six months on semaglutide, then a wall. Switching to tirzepatide under my provider's plan was a second wind — twenty-four more pounds in four months, and I feel sharp again.
- “
By week three I was setting reminders to eat, which has never once been my problem. Energy up, labs better than they've been in a decade.
- “
I asked my provider straight up if the stronger option was worth it for me. She walked me through the trial data and my own history before we decided together. That's the whole reason I stayed.
Frequently Asked
Questions worth asking before you begin.
Every program begins with an online eligibility check and consultation. If your provider authorizes treatment, your protocol is prepared by a partner compounding pharmacy and delivered to your door — with structured check-ins and direct secure messaging to your care team throughout.
Programs are flat-rate with zero hidden fees — no consultation charges, no dose-change surcharges, no insurance required. The price we quote is the price you pay.
No. Eviora MD is a cash-pay telehealth practice, which keeps pricing transparent and lets your provider prescribe based on what's clinically right for you — not what a formulary allows.
A licensed provider reviews and authorizes every consultation. Treatment only moves forward when a provider determines it's appropriate for your health profile.
Memberships may be canceled with 30 days' notice prior to the next billing cycle. Consultations, medical visits, and fulfilled prescriptions are non-refundable once services begin or medication is processed.
Yes. Eviora MD is HIPAA compliant. Your medical information is shared only with your assigned provider and the dispensing pharmacy. We never sell or share your data.
Comparison Protocol
Semaglutide
The proven single-agonist GLP-1 program. Lower trial averages, often the right starting point.
Begin Consultation
The Tirzepatide program begins with a conversation.
Your consultation is reviewed by your dedicated provider. If authorized, your protocol is prepared by a partner compounding pharmacy and delivered direct to your door.